Join the club for FREE to access the whole archive and other member benefits.

Flebogamma

Immune Globulin Intravenous (Human), 10%

One product, two ready to use concentrations

Highly purified, unmodified, 10% concentration human IgG solution

  • Indications: Replacement therapy in primary (inherited) humoral immunodeficiency disorders, such as common variable immunodeficiency, x-linked agammaglobulinemia, severe combined immunodeficiency, and Wiskott-Aldrich Syndrome
  • Broad Safety Margin:
  • High purity 10 % concentration immune globulin
  • Trace amounts of IgA
  • Stabilized with sorbitol
  • Sucrose and maltose free
  • Very low sodium content
  • Liquid: Ready to use. No need for reconstitution
  • Dosing flexibility: 3 vial sizes available, including a 20 g vial

Visit website: https://www.grifols.com/en/product/-/product/united-states/flebogamma_10_dif

See also: Company Grifols - Pharmaceutical company

Details last updated 30-Jun-2020

Flebogamma News

Human trial results of blood plasma exchange for Alzheimer's

Human trial results of blood plasma exchange for Alzheimer's

Aging Matters - 29-Jun-2020

Benefits were seen, but overall results are not impressive